Dynamic Intracellular Metabolic Cell Signaling Profiles During Ag-Dependent B-Cell Differentiation

Abstract

Human B-cell differentiation has been extensively investigated on genomic and transcriptomic grounds; however, no studies have accomplished so far detailed analysis of antigen-dependent maturation-associated human B-cell populations from a proteomic perspective. Here, we investigate for the first time the quantitative proteomic profiles of B-cells undergoing antigen-dependent maturation using a label-free LC-MS/MS approach applied on 5 purified B-cell subpopulations (naive, centroblasts, centrocytes, memory and plasma B-cells) from human tonsils (data are available via ProteomeXchange with identifier PXD006191). Our results revealed that the actual differences among these B-cell subpopulations are a combination of expression of a few maturation stage-specific proteins within each B-cell subset and maturation-associated changes in relative protein expression levels, which are related with metabolic regulation. The considerable overlap of the proteome of the 5 studied B-cell subsets strengthens the key role of the regulation of the stoichiometry of molecules associated with metabolic regulation and programming, among other signaling cascades (such as antigen recognition and presentation and cell survival) crucial for the transition between each B-cell maturation stage.

Deepening into Intracellular Signaling Landscape through Integrative Spatial Proteomics and Transcriptomics in a Lymphoma Model

“…Raw data were analyzed as reported by Paula et al in 2021 [ 34 ]: i. For expression level measuring, the Label-Free Quantification method MaxLFQ [ 35 ] with the MaxQuant Suite v. 1.5.3.30 was used [ 36 ].…”

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

“…With regards to the adaptive response, serum antibodies are essential components of specific immunity but are also involved in the pathogenesis of many autoimmune diseases, allergies, and oncopathologies. While a lot is known about the mechanism of host antibody production following pathogen or infectious exposure or vaccination, the induction of autoantibodies (AABs) in many other diseases still remains to be clearly elucidated (7,8).…”